Bio-Rad Laboratories (BIO) free cash flow

Free cash flow · fiscal 2025
$374.60M

Bio-Rad Laboratories (BIO) generated free cash flow of $374.60M in fiscal 2025 (the year ended December 31, 2025). That is 40.7% higher than the $266.20M of fiscal 2024. Figures as of 19 Nov 2026, 13:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$374.60M
Change on fiscal 2024
+40.7%
Growth, 5 years
−4.7% a year
Growth, 10 years
+17.6% a year
Highest on record
$535.72Mfiscal 2021
Lowest on record
-$7.20Mfiscal 2017
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Rad Laboratories free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 4.7% a year; over ten years the rate was 17.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $535.72M in fiscal 2021 and the lowest -$7.20M in fiscal 2017.

History · 18 fiscal years

Free cash flow by fiscal year

Bio-Rad Laboratories free cash flow, year by year

Bio-Rad Laboratories (BIO) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$374.60M 40.7% up
2024$266.20M 22.0% up
2023$218.20M 172.4% up
2022$80.10M 85.0% down
2021$535.72M 12.4% up
2020$476.41M 32.6% up
2019$359.37M 130.9% up
2018$155.67M—
2017-$7.20M 109.6% down
2016$74.63M 0.6% up
2015$74.21M 51.3% down
2014$152.31M 143.8% up
2013$62.48M 49.5% down
2012$123.61M 22.7% down
2011$159.85M 16.3% up
2010$137.46M 46.5% down
2009$257.03M 141.2% up
2008$106.56M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on BIO

Bio-Rad Laboratories, figure by figure

Bio-Rad Laboratories (BIO) overview: price, valuation and scorecardAll health care companies by market value

Bio-Rad Laboratories free cash flow: questions and answers

What is Bio-Rad Laboratories's free cash flow?

Bio-Rad Laboratories (BIO) generated free cash flow of $374.60M in fiscal 2025 (the year ended December 31, 2025). That is 40.7% higher than the $266.20M of fiscal 2024.

What is the growth rate of Bio-Rad Laboratories's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 4.7% a year; over ten years the rate was 17.6% a year.

What are the highest and lowest free cash flow figures on record for Bio-Rad Laboratories?

Across the 18 fiscal years on record (2008–2025), the highest was $535.72M in fiscal 2021 and the lowest -$7.20M in fiscal 2017.

How is Bio-Rad Laboratories's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Bio-Rad Laboratories it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) free cash flow”, data as of 19 November 2026. https://funkfolio.com/stock/BIO/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.